Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Anesth ; 31(1): 127-139, 2017 02.
Article in English | MEDLINE | ID: mdl-27803982

ABSTRACT

Magnesium, one of the essential elements in the human body, has numerous favorable effects that offer a variety of possibilities for its use in obstetric anesthesia and intensive care. Administered as a single intravenous bolus dose or a bolus followed by continuous infusion during surgery, magnesium attenuates stress response to endotracheal intubation, and reduces intraoperative anesthetic and postoperative analgesic requirements, while at the same time preserving favorable hemodynamics. Applied as part of an intrathecal or epidural anesthetic mixture, magnesium prolongs the duration of anesthesia and diminishes total postoperative analgesic consumption with no adverse maternal or neonatal effects. In obstetric intensive care, magnesium represents a first-choice medication in the treatment and prevention of eclamptic seizures. If used in recommended doses with close monitoring, magnesium is a safe and effective medication.


Subject(s)
Analgesics/administration & dosage , Anesthesia, Obstetrical/methods , Magnesium/administration & dosage , Anesthetics/administration & dosage , Critical Care , Female , Hemodynamics/drug effects , Humans , Pregnancy
2.
J Anesth ; 30(2): 274-83, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26715427

ABSTRACT

The induction-delivery time during Cesarean section is traditionally conducted under light anesthesia because of the possibility of anesthesia-induced neonatal respiratory depression. The serious consequences of such an approach could be the increased risk of maternal intraoperative awareness and exaggerated neuroendocrine and cardiovascular stress response to laryngoscopy, endotracheal intubation, and surgical stimuli. Here, we briefly discuss the various pharmacological options for attenuation of stress response to endotracheal intubation during Cesarean delivery and then focus on remifentanil, its pharmacokinetic properties, and its use in anesthesia, both in clinical studies and case reports. Remifentanil intravenous bolus doses of 0.5-1 µg/kg before the induction to anesthesia provide the best compromise between attenuating maternal stress response and minimizing the possibility of neonatal respiratory depression. Although neonatal respiratory depression, if present, usually resolves in a few minutes without the need for prolonged resuscitation measures, health care workers skilled at neonatal resuscitation should be present in the operating room whenever remifentanil is used.


Subject(s)
Cesarean Section/methods , Intubation, Intratracheal/methods , Piperidines/administration & dosage , Anesthesia, General , Cardiovascular System/metabolism , Female , Humans , Intraoperative Awareness , Laryngoscopy , Pregnancy , Remifentanil
SELECTION OF CITATIONS
SEARCH DETAIL
...